Sage Journals: Discover world-class research

Open access

Research article

First published 2021-7

SGLT2 inhibition does not reduce glucose absorption during experimental peritoneal dialysis

Giedre Martus, Karin Bergling, Javier de Arteaga [...]

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Retricted access

Research article

First published 2025-2

SGLT2 inhibition,circulating biomarkers,and Alzheimer's disease: A Mendelian randomization study

Hao Yang, Yuye Ning, Meilin Chen [...]

Journal of Alzheimer’s Disease

Open access

Research article

First published 2021

SGLT2 Inhibition in Patients With Type 2 Diabetes Mellitus Post-Nephrectomy: A Single-Center Case Series

Marko Škrtić, David Z. I. Cherney, Vikas S. Sridhar [...]

Canadian Journal of Kidney Health and Disease

Open access

Research article

First published 2023-3

Dual SGLT1/SGLT2 inhibitor phlorizin reduces glucose transport in experimental peritoneal dialysis

Giedre Martus, Karin Bergling, Carl M Öberg

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Open access

Research article

First published 2019

How and why SGLT2 inhibitors should be explored as potential treatment option in diabetic retinopathy: clinical concept and methodology

Marcus May, Theodor Framke, Bernd Junker [...]

Therapeutic Advances in Endocrinology and Metabolism

Free access

Research article

First published 2013-9

Nonclinical Toxicology Assessments Support the Chronic Safety of Dapagliflozin,a First-in-Class Sodium-Glucose Cotransporter 2 Inhibitor

Mark Tirmenstein, Thomas E. Dorr, Evan B. Janovitz [...]

International Journal of Toxicology

Retricted access

Research article

First published 2009-7

Dapagliflozin for the Treatment of Type 2 Diabetes

Amie McCord Brooks, Stacey M Thacker

Annals of Pharmacotherapy

Retricted access

Editorial

First published 2023-3

SGLT2 inhibition,glucose transport and peritoneal dialysis: Finding the sweet spot

Vikas S Sridhar, Donald J Fraser

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Open access

Review article

First published 2021

The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fraction

Michael V. Genuardi, Paul J. Mather

Therapeutic Advances in Cardiovascular Disease

Free access

Research article

First published 2015-3

Development of sotagliflozin,a dual sodium-dependent glucose transporter 1/2 inhibitor

Pablo Lapuerta, Brian Zambrowicz, Paul Strumph [...]

Diabetes & Vascular Disease Research

Search results